SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001033427-10-000027
Filing Date
2010-01-28
Accepted
2010-01-28 13:21:19
Documents
2
Group Members
DAVID L. COHENHAROLD J. LEVY

Document Format Files

Seq Description Document Type Size
1 PDL 13G/A 12-31-09 pdl13ga2123109.htm SC 13G/A 110469
2 JOINT FILING AGREEMENT pdlex99.htm EX-99 10927
  Complete submission text file 0001033427-10-000027.txt   123438
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Subject) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43256 | Film No.: 10553074
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 276 POST ROAD WEST WESTPORT CT 06880-4704
Business Address 276 POST RD WEST WESTPORT CT 06880-4704 2033417800
IRIDIAN ASSET MANAGEMENT LLC/CT (Filed by) CIK: 0001033427 (see all company filings)

IRS No.: 061439577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A